Home Bristol Myers Squibb

Bristol Myers Squibb

In operation
-
Therapeutic Drug Developer
Basic
Enterprise Profile

Basic Information

Bristol-Myers Squibb is committed to addressing the significant unmet medical needs in China, with a primary focus on viral hepatitis and immuno-oncology. The company aims to introduce groundbreaking innovative products in the fields of immuno-oncology, hematology, and immunology, lead industry advancements, engage in diverse collaborations, and help Chinese patients overcome severe diseases.
Bristol-Myers Squibb China Pharmaceuticals Co., Ltd
Jiangsu,China
15~50 people
August 30, 2013
yi.yu@bms.com

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Concept
Tumor Immune System Diseases Hematologic Diseases Therapeutic Products Hepatitis
Application Scenarios
Innovative Drugs